# Comprehensive Proteomics Metadata and Integrative Web Portals Facilitate Sharing and Integration of LINCS Multiomics Data

**Authors:** Dušica Vidović, Behrouz Shamsaei, Stephan C. Schürer, Phillip Kogan, Szymon Chojnacki, Michal Kouril, Mario Medvedovic, Wen Niu, Evren U. Azeloglu, Marc R. Birtwistle, Yibang Chen, Tong Chen, Jens Hansen, Bin Hu, Ravi Iyengar, Gomathi Jayaraman, Hong Li, Tong Liu, Eric A. Sobie, Yuguang Xiong, Matthew J. Berberich, Gary Bradshaw, Mirra Chung, Robert A. Everley, Ben Gaudio, Marc Hafner, Marian Kalocsay, Caitlin E. Mills, Maulik K. Nariya, Peter K. Sorger, Kartik Subramanian, Chiara Victor, Maria Banuelos, Victoria Dardov, Ronald Holewinski, Danica-Mae Manalo, Berhan Mandefro, Andrea D. Matlock, Loren Ornelas, Dhruv Sareen, Clive N. Svendsen, Vineet Vaibhav, Jennifer E. Van Eyk, Vidya Venkatraman, Steve Finkbiener, Ernest Fraenkel, Jeffrey Rothstein, Leslie Thompson, Jacob Asiedu, Steven A. Carr, Karen E. Christianson, Desiree Davison, Deborah O. Dele-Oni, Katherine C. DeRuff, Shawn B. Egri, Alvaro Sebastian Vaca Jacome, Jacob D. Jaffe, Daniel Lam, Lev Litichevskiy, Xiaodong Lu, James Mullahoo, Adam Officer, Malvina Papanastasiou, Ryan Peckner, Caidin Toder, Joel Blanchard, Michael Bula, Tak Ko, Li-Huei Tsai, Jennie Z. Young, Vagisha Sharma, Ajay Pillai, Jarek Meller, Michael J. MacCoss

PMC · DOI: 10.1016/j.mcpro.2025.100947 · Molecular & Cellular Proteomics : MCP · 2025-03-13

## TL;DR

The LINCS program created a standardized, accessible proteomics data library to support research on cellular responses to various perturbations.

## Contribution

Development of metadata standards and integrative tools to harmonize and share LINCS proteomics data across multiple platforms.

## Key findings

- LINCS proteomics data from four centers use diverse technologies like P100, tandem mass tags, and SWATH.
- Metadata standards ensure compatibility with community platforms and FAIR data principles.
- Tools like the LINCS Data Portal and piNET enable exploration and analysis of proteomics signatures.

## Abstract

The Library of Integrated Network-based Cellular Signatures (LINCS), an NIH Common Fund program, has cataloged and analyzed cellular function and molecular activity profiles in response to >80,000 perturbing agents that are potentially disruptive to cells. Because of the importance of proteins and their modifications to the response of specific cellular perturbations, four of the six LINCS centers have included significant proteomics efforts in the characterization of the resulting phenotype. This manuscript aims to describe this effort and the data harmonization and integration of the LINCS proteomics data discussed in recent LINCS papers.

•The Library of Integrated Network-Based Cellular Signatures (LINCS) has diverse data.•Targeted proteomics, data-dependent/independent acquisition technologies utilized.•Metadata standards harmonize data and ensure compatibility with community platforms.•LINCS tools make proteomics signatures accessible for exploration and analysis.

The Library of Integrated Network-Based Cellular Signatures (LINCS) has diverse data.

Targeted proteomics, data-dependent/independent acquisition technologies utilized.

Metadata standards harmonize data and ensure compatibility with community platforms.

LINCS tools make proteomics signatures accessible for exploration and analysis.

The Library of Integrated Network-Based Cellular Signatures (LINCS) built a FAIR-aligned library of cellular response signatures to support disease research and drug discovery. LINCS proteomics data were generated at four centers using diverse technologies like P100, tandem mass tags, and SWATH to study cancer, cardiotoxicity, and neurodegenerative diseases. Metadata standards were developed to harmonize data and ensure compatibility with community platforms. LINCS tools, such as the Data Portal and piNET, make these proteomics signatures easily accessible for exploration and analysis.

## Linked entities

- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase) [NCBI Gene 25] {aka ABL, BCR-ABL, CHDSKM, JTK7, bcr/abl, c-ABL}, GOLGB1 (golgin B1) [NCBI Gene 2804] {aka GCP, GCP372, GOLIM1}, BTK (Bruton tyrosine kinase) [NCBI Gene 695] {aka AGMX1, AT, ATK, BPK, IGHD3, IMD1}, OAS3 (2'-5'-oligoadenylate synthetase 3) [NCBI Gene 4940] {aka p100, p100OAS}, CDK2 (cyclin dependent kinase 2) [NCBI Gene 1017] {aka CDKN2, p33(CDK2)}, CDK1 (cyclin dependent kinase 1) [NCBI Gene 983] {aka CDC2, CDC28A, P34CDC2}
- **Diseases:** neurodegenerative diseases (MESH:D019636), SMA (MESH:D009134), cancer (MESH:D009369), Toxicity (MESH:D064420), ALS (MESH:D000690), LDP (MESH:D019292), Alzheimer's disease (MESH:D000544), heart failure (MESH:D006333), Neurological Disease (MESH:D020271), cardiotoxicity (MESH:D066126), motor neuron diseases (MESH:D016472)
- **Chemicals:** Dinaciclib (MESH:C553669), Flavopiridol (MESH:C077990), staurosporine (MESH:D019311), Dasatinib (MESH:D000069439)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12332945/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12332945/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC12332945/full.md

---
Source: https://tomesphere.com/paper/PMC12332945